Key result
Cost-effectiveness analysis can improve decisions about appropriate technology use in interventional pediatric cardiology.
This article reviews the principles of cost-effectiveness analysis and its application to interventions in pediatric cardiology, such as patent ductus arteriosus closure.
May inform technology adoption decisions in interventional pediatric cardiology; leaves open procedure-specific prospective validation.
Expansion of the options available for the treatment of congenital heart disease has been accompanied by an increasing realization of the limits of our available health care resources. Cost-effectiveness analysis is one of several analytic approaches that can improve decisions about the appropriate use of technology in interventional pediatric cardiology and other fields. In this article, cost-effectiveness analysis is distinguished from related approaches, such as cost-benefit analysis. Then, basic principles of cost-effectiveness analysis are described. Next, the application of these principles is illustrated, using a recently published comparison of transcatheter versus surgical closure of patent ductus arteriosus. Finally, potential research implications of the surprising findings of this study are discussed.
No takes yet. Share an insight, caveat, or question.
A 1995 study conducted a review in Congenital heart disease. Cost-effectiveness analysis was evaluated. Cost-effectiveness analysis is an analytic approach that can improve decisions about the appropriate use of technology in interventional pediatric cardiology.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: